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Background: Health care providers routinely undertreat tobacco dependence, indicating a need for innovative ways to
increase delivery of evidence-based care. Lean, a set of quality improvement (QI) tools used increasingly in health care, can
help streamline processes, create buy-in for use of evidence-based practices, and lead to the identification of solutions on
the basis of a problem’s root causes. To date, no published research has examined the use of Lean tools in tobacco depen-
dence. A 12-month QI project using Lean tools was conducted to increase delivery of evidence-based tobacco use treatment
(TUT) to hospitalized neurosurgical patients.
Methods: The study team developed a nicotine replacement therapy (NRT) and counseling protocol for neurosurgery
inpatients who indicated current tobacco use and used Lean tools to increase protocol adherence. Rates of NRT prescrip-
tion, referrals to counseling, and follow-up phone calls were compared pre- and postintervention. Secondary measures included
patient satisfaction with intervention, quit rates, and reduction rates at 4 weeks postdischarge.
Results: Referrals to counseling doubled from 31.7% at baseline to 62.0% after implementation of the intervention, and
rates of nicotine replacement therapy (NRT) prescriptions during hospitalization and at discharge increased from 15.3% to
28.5% and 9.0% to 19.3%, respectively. Follow-up phone call rates also dramatically increased. The majority of satisfac-
tion survey respondents indicated that counseling had a positive or neutral impact on stress level and overall satisfaction.
Conclusion: Lean tools can dramatically increase use of evidence-based TUT in hospitalized patients. This project is easily
replicable by professionals seeking to improve delivery of tobacco treatment. These findings may be particularly helpful to
inpatient surgical departments that have traditionally been reticent to prescribe NRT.
Tobacco use is the leading preventable cause of morbidityand mortality across the globe, causing approximately
six million deaths each year.1,2 Evidence-based tobacco use
treatment (TUT) that includes behavioral counseling and
pharmacotherapy is highly effective and affordable in both
inpatient and outpatient settings.3–6 These interventions may
greatly reduce tobacco-related illness and death.5 Yet health
care providers routinely undertreat tobacco dependence.7 The
need for innovative ways to increase delivery of evidence-
based care is urgent.
Clinical practice guidelines assert the benefits of combin-
ing counseling with pharmacotherapy to optimize tobacco
quit rates.6,8,9 A 2012 Cochrane review of TUT for hospi-
talized patients concludes that interventions beginning in the
hospital and including at least one month of follow-up are
most effective.10 For the purpose of this article, evidence-
based care includes clinical practice guidelines and the
Cochrane review recommendations. Implementation of an
“opt-out” automated and universal TUT inpatient program
consistent with The Joint Commission’s Tobacco Treat-
ment (TOB) performance measures for hospitals11 has proven
to be feasible.12,13 A study in Australia showed that the
provision of evidence-based TUT to inpatients increased after
implementation of a multifaceted quality initiative but that
only 21.4% of patients with tobacco dependence received
advice to quit, which represents the lowest level of quality
care, highlighting the need for additional strategies to op-
timize care delivery.14 Many hospitals in Canada15 and
England,16 for example, routinely offer universal TUT coun-
seling and nicotine replacement therapy (NRT); however,
this practice is rare in the United States and other countries.
While strong evidence supports the efficacy of addressing
tobacco use in hospitalized patients, the many competing
demands of acute care in inpatient settings often place it at
a lower priority for busy providers.17 Quality improvement
(QI) techniques adopted from other industries are now widely
used in health care to address gaps in quality care delivery
and may be helpful in increasing the provision of evidence-
based TUT to hospitalized patients.
Lean QI strategies, originally developed by the Toyota
Motor Company, emphasize using the scientific method (A3
problem solving) to involve frontline providers in solving their
problems related to work flow and quality care delivery, with
a focus on increasing value delivered to the customer.18 Lean
philosophy focuses on customers,who may be patients, pro-
viders, or other stakeholders, depending on the process under
examination.19 The A3 consists of nine boxes or steps to plan,
execute, and evaluate experiments,20,21 which were used to
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structure this project (Figure 1). Although some studies
support the use of Lean tools in health care, including ap-
plication in pediatrics,22 neurosurgery,23 and radiology,24 more
research is warranted to fully evaluate Lean methodology
within health care settings.25
Surgical inpatient services have led the medical field in
incorporating QI tools into regular work flow (for example,
surgical checklists, time-outs),26 but they have been hesitant
to adopt TUT protocols, primarily because of misconceptions
about the safety of NRT use in surgical patients.27 To our
knowledge, no literature exists regarding use of Lean QI tools
within the field of TUT. In this article, we report findings
from a 12-month QI project using Lean tools to optimize




This one-year study (January 1, 2015–December 31, 2015)
was conducted at a large academic medical center in the
southeastern United States in which tobacco treatment spe-
cialists (TTSs) provide bedside consults to hospitalized patients
and postdischarge telephone counseling as part of a com-
prehensive tobacco treatment service. Study #15–3324
(Principal Investigator, Oluwaseun Omofoye) was ap-
proved by the Institutional Review Board of the University
of North Carolina at Chapel Hill.
We now describe the study in terms of its phases, with
a focus on (1) the introduction of a protocol with guide-
lines for referrals to counseling, prescription of NRT and
post-discharge telephone counseling creation and post-
discharge telephone counseling and (2) the subsequent
application of Lean QI tools to advance implementation of
the protocol.
Introduction of the Protocol
In an April 2014 presentation at Neurosurgery Grand Rounds,
two TTSs [L.S., A.O.G.], emphasized the safety of NRT and
the benefits of cessation to neurosurgical patients. They also
provided performance feedback regarding the service’s use
of evidence-based cessation practices—data for the January–
March 2014 period indicated that only one third of
neurosurgical patients who smoke were referred for coun-
seling and that fewer patients received NRT. A neurosurgery
resident [O.O.] volunteered to work with the TTSs on de-
veloping a protocol aimed at improving delivery of evidence-
based care, and they recruited other frontline providers (a
nurse practitioner and nurse manager) to form a
Title: Using Lean Quality Improvement Tools to Increase Delivery of Evidence-based Tobacco Use Treatment (TUT) in Hospitalized Neurosurgical Paents
A3 Team Lead: Laurel Sisler A3 Start Date: 3/1/2015 Sensei:
Box 1. Reason for Acon
PROBLEM STATEMENT: Tobacco cessaon improves post-operave outcomes in 
neurosurgerical paents, yet only a small fracon of eligible paents at our hospital 
receive evidence-based tobacco use treatment.  
IMPORTANCE STATEMENT: Offering systemac evidence-based tobacco use treatment to 
all eligible paents will improve paents' post-op healing and quality of life, and reduce 
their likelihood of developing many chronic and life-threatening health condions. 
Paents want tobacco use to be addressed in the hospital and offering best pracce care 
will improve paent sasfacon. 
IN SCOPE: Counseling & NRT for paents on the inpaent neurosurgical service and post-
discharge counseling phone calls. OUT OF SCOPE: other hospital services, 
Varenicline/Bupropion prescripons, paents under 18. 
Box 4. Gap Analysis, Five Why's
# Acon Owner Due Status
1 CTTS offers inpaent TUT counseling and post-discharge 
phone follow-up to all referred paents 
Laurel Sisler 01/01/15 Ongoing
2 CTTS aends weekly interdisciplinary meengs Laurel Sisler 04/01/15 Ongoing
4 Orders for counseling & NRT added to several 
neurosurgery order sets
Seun Omofoye 04/01/15 Done
5 Send monthly updates to QI team on performance 
metrics






Box 7. Compleon Plan
Tobacco use added to RN manager checklist on post-op 
floor
Emily Ryan 04/01/15 Done3
Metric Unit Current Target
Primary Paents referred for tobacco counseling % 31.7 80
Primary Paents prescribed NRT while inpaent % 15.3 40
Primary Paents discharged with script for NRT % 9 40
Primary Aempted post-discharge phone calls per month # calls / mns 1.5 28
Secondary




Pts reporng consult had posive or neutral impact on overall 
sasfacon 
% N/A 100
Secondary Tobacco free paents at 4-weeks post discharge % N/A 30
Secondary Pts w/ reduced smoking at 4-weeks post discharge % N/A 30
Box 2. Current State & Box 3. Target State - True North Metrics
Counseling & NRT protocol caused an inial spike in referrals & 
NRT prescripons, but the increase was not sustained. Most 
paents are not offered evidence-based tobacco use 
treatment, including NRT, inpaent counseling and post-
discharge follow-up telephone calls. 
Current State Target State
1) 40% of all paents who indicate current smoking on 
admission are prescribed NRT while hospitalized and at 
discharge, and 80% are referred for counseling.  2) We call 
paents at 1, 4, 12 and 24 weeks post-discharge to assess 
their level of tobacco use and offer ongoing behavioral 
counseling.  3) Paent sasfacon and stress levels are 
assessed and found to be posively correlated with the 
care delivered.
# Soluon (if we) Outcome (then we) Gap No. 
1
If CTTS parcipates in weekly 
interdisciplinary rounds on post-op floor, 
Staff will have a weekly reminder to 




If RN manager adds tobacco use to daily 
checklist, 
Resident will have a daily reminder to 




If tobacco use counseling and NRT are added 
to common neurosurgery post-op order sets, 
More eligible paents will receive best 




Box 5. Soluon Approach (SA)
















Tobacco use added 
to RN manager 
checklist on post-op 
floor
Orders for 
counseling & NRT 




& more likely to 
write orders & refer
Orders for counseling 
& NRT doubled











Orders for counseling 
& NRT doubled
On-call resident 
reminded & more 
likely to write 
orders & refer
Providers more 
likely to write 
orders & refer
Orders for counseling 
& NRT doubled




Metric Unit Current Target 60-Day 6-Mns 12-Mns Year 2
P Paents referred for tobacco counseling % 31.7 80 34.5 62.8 70.2 47.3
P Paents prescribed NRT while inpaent % 15.3 40 14.6 22.2 37.6 29.8
P Paents discharged with script for NRT % 9 40 5.4 16.4 25.4 20
P
Aempted post-discharge phone calls per 
month
# calls / 
mns 1.5 28 7 26 31 7
S
Pts reporng consult had posive or neutral 
impact on overall sasfacon 
% N/A 100 N/A N/A >90 N/A
S
Pts reporng consult had + or neutral impact 
on stress while hospitalized
% N/A 90 N/A N/A 79 N/A
S
Tobacco free paents at 4-weeks post 
discharge
% N/A 30 N/A N/A 15 N/A
S
Paents w/ reduced smoking at 4-weeks post 
discharge
% N/A 30 N/A N/A 13 N/A
Box 8. Confirmed State - True North Metrics
Box 9. Insights
What went well or helped?
Front-line staff buy-in, fostered through relaonships, was crical
Physician champion (resident) was necessary
Teams were responsive to performance feedback, compeve culture was helpful
Strategies originang from A3 thinking increased sustainability in key metrics
What can be improved next me?
Gather more complete data describing the current state
Test relave effecveness of different strategies in Box 6
What will we do differently now?
Connue three intervenons that came out of this A3
Provide monthly performance feedback to QI team and re-engage in the connual 
improvement process (using another A3) if numbers drop below the new standard
How will we share lessons learned with others? 
Dessiminaon at 2 conferences and hospital's Quality Expo
Publicaon in peer-reviewed journal
Iniang similar QI projects with other inpaent hospital services
Team Members: Seun Omofoye MD, Emily Ryan RN, Helen Mitchell NP, Laurel Sisler CTTS LCSW. Advisors: Adam Goldstein MD, Eldad Hadar MD & Carol Ripley-Moffi MDiv CTTS
Figure 1: The A3, as shown, depicts in detail the quality improvement process used by the study team. The A3 consists
of nine boxes or steps to plan, execute and evaluate experiments, which were used to structure the project. NRT, nicotine
replacement therapy; CTTS, Certified Tobacco Treatment Specialist; QI, quality improvement; MNs, months.
multidisciplinary team. The study team’s Reason for Action
is shown in Figure 1 (Box 1). Between April and Decem-
ber 2014, the team created, marketed, and disseminated a
new protocol with guidelines for referrals to counseling, pre-
scription of NRT, and postdischarge telephone counseling
(Figure 2). Providers were educated about the protocol in
staff meetings, huddles, and Grand Rounds. The use of the
protocol appeared to result in a short-term increase in re-
ferrals for counseling and rates of NRT prescription. However,
the change was not sustained beyond two months. Several
team members had participated in the Lean training offered
by the health care system, and in March 2015 the team
Neurosurgery Nicotine Replacement Therapy (NRT) and Tobacco Use Treatment
Consult Protocol
Figure 2: This protocol guided the prescription of nicotine replacement therapy and provision of tobacco use treatment
counseling and follow-up in neurosurgical patients, January 2015 onward. Pt, patient; Hx, history; MI, myocardial infarc-
tion; SAH, subarachnoid hemorrhage; SRN, neurosurgery.
decided to test Lean tools in the context of neurosurgical
inpatient TUT.
Application of the Lean QI Tools
Following the A3 problem-solving tool, the team first mapped
out its Current and Future Desired (Target) States (Boxes 2
and 3, Figure 1). Then, in examining the gap between the
Current and Future Desired State, the team used the “Five
Whys”; that is, asked why the gap exists five consecutive times
to determine root causes for the gap between evidence-
based practice and current state (Box 4, Figure 1).28 The
team identified one likely root cause—treating tobacco
dependence is not neurosurgeons’ primary job. Frequently,
neurosurgeons have urgent clinical issues that absorb
their time, so preventive measures such as cessation ser-
vices for tobacco use, albeit important, are not priorities for
them.
The frontline neurosurgery providers demonstrated com-
mitment to helping their patients with tobacco dependence
by fully supporting this QI project, but they requested as-
sistance in remembering to order evidence-based treatment.
With this root cause and input from stakeholders in mind,
the study team then tested three solution strategies (Boxes 5,
6, and 7, Figure 1) aimed at delivering better care to hos-
pitalized patients who smoke: (1) TTS attendance at weekly
interdisciplinary unit meetings, (2) tobacco use added to
checklist reviewed by resident and nurse manager each
morning, and (3) NRT and order for TTS consult added
to multiple neurosurgery order sets.
Participants
During the study year (January 1, 2015–December 31, 2015),
337 patients 18 years of age or older who indicated current
tobacco use (that is, in the 30 days prior to admission) were
admitted to the inpatient neurosurgical service. The average
age of the study patients was 49 years, with the majority
(66%) of patients falling between 40 and 70 years of age.
The historical control group consisted of 189 neurosurgi-
cal patients who indicated tobacco use on admission between
July 1, 2014, and December 31, 2014. The average age of
the study patients in the control group was 52 years, with
the majority (68%) of the patients falling between 40 and
70 years of age. Some 342 patients meeting the same cri-
teria were admitted in 2016, and their data were included
to report on sustainability. The participant flow from ad-
mission to follow-up is shown in Figure 3.
Primary Measures
The team monitored rates of NRT prescription (both during
hospitalization and at discharge), counseling referrals, and
average follow-up phone calls attempted per month from
July 1, 2014, to December 31, 2016. At four weeks
Flow of Eligible Patients from Admission to Follow-Up, July 2014–December 2016
Figure 3: During the study year (January 1, 2015–December 31, 2015), 337 patients ≥ 18 years of age, who indicated current
tobacco use (that is, in the 30 days prior to admission) were admitted to the inpatient neurosurgical service. The historical
control group consisted of 189 neurosurgical patients who indicated tobacco use on admission between July 1, 2014, and
December 31, 2014. TUT, tobacco use treatment.
viewed by study personnel each month. Study personnel used
Microsoft Excel (Microsoft Corp., Redmond Washington)
to compute descriptive statistics, comparing aggregated data
from the historical control to the intervention period.
Outcome data for the primary measures from the year after
the intervention were also included to demonstrate
sustainability. Team members manually entered survey re-
sponses into and analyzed aggregated data in Qualtrics (Provo,
Utah), a secure Internet-based survey tool.
RESULTS
Primary Measures
As shown in Box 8 (Figure 1), following implementation of
Lean tools and the resulting strategies, utilization of all
evidence-based TUT practices doubled. Sixty-two percent
(209) of the 337 neurosurgical patients who smoke were
referred for counseling postintervention, compared to 60 of
189 (31.7%) preintervention. Similarly, rates of inpatient
NRT prescription increased from 15.3% (29 of 189 pa-
tients) to 28.5% (96 of 337), and the rates of discharge NRT
prescription increased from 9.0% (17 of 189) to 19.3% (65
of 337) (Figure 4). During the study year, an average of 31
follow-up phone calls were attempted per month, compared
to 1.5 per month preintervention. In the subsequent year,
high NRT prescription rates were sustained (29.8% for in-
patient and 20% for discharge). Referrals for counseling and
follow-up phone calls rates reduced to 47.3% (still up nearly
50% from preintervention) and 7 per month, respectively.
Secondary Measures
Patient Satisfaction Survey. Over the study period, 209
of the 337 patients with current tobacco use status were re-
ferred for counseling. Of these 209 patients, 45 did not receive
counseling because they died prior to discharge (n = 4), were
Percentage of Neurosurgery Tobacco Users Receiving Evidence-Based
Treatment, Pre- vs. Postintervention
Figure 4: The graph shows the change in counseling referrals and rates of nicotine replacement therapy (NRT) prescrip-
tion, pre- vs. postintervention for three of four primary measures. For example, 209 (62.0%) of the 337 neurosurgical patients
who smoke were referred for counseling postintervention, compared to 60 (31.7% of 189 patients) preintervention.
postdischarge, study personnel made three attempts to reach 
every patient who received counseling while hospitalized 
(N = 164) for postdischarge follow-up telephone counsel-
ing. The measures (“Metrics”) are shown in Box 2, Figure 1. 
Patients with certain diagnoses were excluded from receiv-
ing NRT, as shown in Figure 2, but were still included in 
the denominator because diagnosis information was not in 
our data set.
Measures
Primary Measures. We chose to primarily measure pro-
cesses (referrals, prescriptions, attempted calls) rather than 
outcomes (receipt of counseling, administration of NRT, quit 
rates) because research had shown that implementing these 
processes results in improved patient outcomes.6,10
Secondary Measures. The quit and reduction rates were 
calculated as secondary outcomes data (Box 2, Figure 1) col-
lected during follow-up calls. Also, we developed a pen-
and-paper patient satisfaction survey, which was given on 
the day of discharge (Appendix 1, available in online article). 
The survey assessed the acceptability of universal TUT coun-
seling from the patient perspective, in line with Lean’s 
emphasis on delivering value to the patient. It also ad-
dressed the concerns of several neurosurgeons that TUT 
counseling might increase stress levels and reduce satisfac-
tion among their patients. Floor nurses delivered the survey 
and collected it prior to discharge. Study personnel collect-
ed surveys weekly.
Data Analysis
Health care system analysts developed a report on rates of 
NRT prescription and referral to counseling with input from 
the study team and data from the electronic health record. 
This report was saved on a secure shared drive and re-
too cognitively impaired (n = 23), did not speak English—
the survey was not translated by the hospital’s translation
services in time for its use in the study period. (n = 3), refused
counseling (n = 4), or were discharged prior to completion
of counseling consult (n = 11). Of the remaining 164 pa-
tients who were eligible to receive the survey, 64 completed
it. One respondent did not remember meeting the TTSs,
resulting in 63 complete surveys (38.4% response rate). More
than 90% of the respondents indicated that the counseling
had a positive or neutral impact on their overall satisfac-
tion with their hospital stay, 89% were satisfied with the
counseling provided, 79% indicated that the counseling de-
creased or had no impact on their stress level during their
hospital stay,” and 73% reported increased confidence in their
ability to quit after talking with the counselor.
Quit and Reduction Rates. At four weeks postdischarge,
90 of the 164 counseled inpatients were reached on the phone
(54.9% follow-up rate), 25 of whom reported being tobacco
free since discharge. An additional 21 patients had reduced
their cigarette consumption by greater than half, compared
to pre-hospitalization. Using intent-to-treat analysis, by which
all eligible patients are included in the analysis whether reached
on the phone or not,29 the quit rate was 15.2%.
DISCUSSION
Inpatient tobacco cessation interventions that include at least
one month of postdischarge follow-up are effective in in-
creasing quit rates,10 yet few hospitals fully implement this
type of program. A neurosurgical service within a large ac-
ademic medical center in the southeastern United States
identified the need to improve delivery of evidence-based
TUT. We describe the successful implementation of a QI
project on this service in this article, which is noteworthy,
we believe, for several reasons. First, to the best of our knowl-
edge, it is the only published description of a comprehensive
successful TUT program for hospitalized neurosurgical pa-
tients. The extensive rewards to neurosurgical patients of
becoming tobacco free include primary and secondary stroke
prevention, reduced incidence of infections, and improved
wound healing.30,31 Lean tools proved to be an effective way
to increase delivery of evidence-based care to this at-risk
patient group.
Second, like neurosurgeons, many other surgeons are
reluctant to prescribe NRT because of concerns about the
impact of NRT on vasoconstriction and wound healing—
concerns that arise largely from experimental studies.32,33
Despite literature that supports the safety of NRT and dem-
onstrates no increased risk of vasospasm or impaired wound
healing,27,30,34–38 knowledge and acceptance of this literature
remains low among surgeons.39 The current study demon-
strates an effective means to provide surgeons and other staff
with updated education about NRT, create a safe NRT pro-
tocol for surgical patients, and change culture in support of
evidence-based TUT. Other surgical units may use this model
for treating tobacco dependence while maintaining patient
safety as a top priority.
Third, this project highlights a successful intervention de-
livered to hospitalized patients. For example, both inpatient
and discharge NRT prescription rates doubled—to 28.5%
and 19.3%, respectively. These percentages would likely have
been even higher, except that two categories of patients were
exempt from receiving NRT—those with a subarachnoid
hemorrhage (SAH) and those requiring instrumented spinal
fusion. Retrospective analysis showing that NRT does not
increase risk of vasospasm in patients with SAH34 did not
change neurosurgeons’ perspective that NRT is too risky in
this vulnerable population. Preclinical data suggesting that
high levels of nicotine are associated with delayed spinal fusion
rates in rabbits40 and rats41 led to the decision to exclude this
patient population. These two categories combined make up
54% of all neurosurgical patients at the study hospital, re-
gardless of their smoking status, admitted in 2015. Within
our study sample and control group, the percentage of pa-
tients in these excluded categories is unknown because
diagnosis information was not in our study data set, but likely
a substantial portion of those who did not receive NRT were
ineligible for NRT.
Fourth, these data may have financial implications. Health
care systems may lose money when they miss opportunities
to help patients stop smoking. Evidence suggests that pa-
tients admitted for cardiovascular problems, including stroke,
who continue smoking postdischarge are at increased risk
of readmission.42–46 Novel strategies to increase delivery of
evidence-based care are necessary, and our project suggests
that Lean tools may be a promising strategy to reach this goal.
Finally, the patient satisfaction survey data were encour-
aging, as the TTS consults were well received, with nearly
90% of respondents reporting satisfaction with the treat-
ment provided. While a 38.4% response rate for patient
satisfaction surveys was not ideal, we identified two primary
barriers to completion: the plethora of tasks requiring nurse
attention prior to discharge and the inability of some pa-
tients to complete the survey. The latter reflects a real barrier
to surveying patients when recent nervous system patholo-
gy results in limited cognitive capacity.
To sustain progress, the project team provides monthly
performance reports to neurosurgery stakeholders on primary
metrics. Staff members receive routine reminders about the
new work flow at quarterly nurse staff meetings, during bi-
annual physician Grand Rounds, and during neurosurgery
intern orientation each July. This strategy has been suffi-
cient to maintain the new status quo for NRT prescription
rates. Referrals for counseling reduced slightly in 2016, likely
related to fewer referrals for patients with compromised neu-
rological status. Follow-up phone call rates consequently
decreased as well. The satisfaction survey, which required con-
siderable staff time, was not continued beyond the study year.
If different implementation strategies are needed in the future,
the team will start another improvement cycle using Lean
rates in neurosurgical patients comparing usual care to
evidence-based practice.
CONCLUSION
We have demonstrated that Lean tools can assist inpatient
hospital units to increase delivery of evidence-based TUT
for the reduction of tobacco-related morbidity and mortal-
ity. More research is needed to determine if this model is
effective on other inpatient units and in other settings. In
addition, the satisfaction data may alleviate concerns about
the acceptability of universal tobacco treatment counseling
among hospitalized patients who smoke.
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